Shabir Madhi

Shabir_Madhi_for_Fundación_Civio

Shabir Madhi is a prominent South African vaccinologist and infectious disease expert. He is known for his extensive research in the field of vaccinology, particularly in the development and testing of vaccines for pneumococcal disease, rotavirus, and more recently, COVID-19.

Early Life and Education

Shabir Madhi was born in South Africa. He completed his medical degree at the University of the Witwatersrand in Johannesburg. He later pursued a specialization in pediatrics and obtained a PhD in vaccinology.

Career

Madhi has held several key positions in the field of infectious diseases and vaccinology. He is a professor of vaccinology at the University of the Witwatersrand and the Executive Director of the South African Medical Research Council's Vaccines and Infectious Diseases Analytics Research Unit (VIDA).

He has been involved in numerous clinical trials and has contributed significantly to the understanding and prevention of infectious diseases in Africa. His work has been instrumental in the introduction of the pneumococcal conjugate vaccine and the rotavirus vaccine into the South African national immunization program.

COVID-19 Research

During the COVID-19 pandemic, Madhi played a crucial role in the clinical trials for the Oxford-AstraZeneca COVID-19 vaccine in South Africa. His research provided important insights into the efficacy of the vaccine against the Beta variant of the virus, which was first identified in South Africa.

Awards and Recognition

Shabir Madhi has received numerous awards for his contributions to medical science and public health. He is a member of several prestigious organizations, including the Academy of Science of South Africa.

Publications

Madhi has authored and co-authored numerous scientific papers in high-impact journals. His research has significantly influenced public health policies and vaccine strategies in South Africa and globally.

Related Pages

• Vaccinology
• Infectious disease
• Pneumococcal disease
• Rotavirus
• COVID-19 pandemic
• Oxford-AstraZeneca COVID-19 vaccine
• University of the Witwatersrand
• South African Medical Research Council